van den Bosch Tom, Derks Sarah, Miedema Daniël M
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam University Medical Centers-Location AMC, 1105 AZ Amsterdam, The Netherlands.
Oncode Institute, 1105 AZ Amsterdam, The Netherlands.
Cancers (Basel). 2022 Oct 12;14(20):4986. doi: 10.3390/cancers14204986.
Intra-tumor heterogeneity (ITH) is a pan-cancer predictor of survival, with high ITH being correlated to a dismal prognosis. The level of ITH is, hence, a clinically relevant characteristic of a malignancy. ITH of karyotypes is driven by chromosomal instability (CIN). However, not all new karyotypes generated by CIN are viable or competitive, which limits the amount of ITH. Here, we review the cellular processes and ecological properties that determine karyotype ITH. We propose a framework to understand karyotype ITH, in which cells with new karyotypes emerge through CIN, are selected by cell intrinsic and cell extrinsic selective pressures, and propagate through a cancer in competition with other malignant cells. We further discuss how CIN modulates the cell phenotype and immune microenvironment, and the implications this has for the subsequent selection of karyotypes. Together, we aim to provide a comprehensive overview of the biological processes that shape the level of karyotype heterogeneity.
肿瘤内异质性(ITH)是一种泛癌生存预测指标,ITH水平高与预后不良相关。因此,ITH水平是恶性肿瘤的一个临床相关特征。核型的ITH是由染色体不稳定性(CIN)驱动的。然而,并非所有由CIN产生的新核型都是可行的或具有竞争力的,这限制了ITH的程度。在这里,我们回顾了决定核型ITH的细胞过程和生态特性。我们提出了一个理解核型ITH的框架,在这个框架中,具有新核型的细胞通过CIN出现,受到细胞内在和外在选择压力的筛选,并在与其他恶性细胞的竞争中在肿瘤中增殖。我们进一步讨论了CIN如何调节细胞表型和免疫微环境,以及这对随后核型选择的影响。我们共同旨在全面概述塑造核型异质性水平的生物学过程。